US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

13.89

0.0000

Post-market: 14.000.1100+0.79%19:01 EDT

Volume:1.01M

Turnover:14.05M

Market Cap:618.96M

PE:-9.19

High:14.26

Open:13.78

Low:13.71

Close:13.89

52wk High:32.71

52wk Low:8.80

Shares:44.56M

Float Shares:24.29M

Volume Ratio:1.14

T/O Rate:4.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5114

EPS(LYR):-1.8100

ROE:-22.71%

ROA:-15.04%

PB:2.28

PE(LYR):-7.67

Loading ...

Overview Company News Filings

Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25

Beta Bionics director Christy Jones sells 2,811 shares worth $39,354

Beta Bionics management to meet with Piper Sandler

Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

Beta Bionics Is Maintained at Buy by Goldman Sachs

Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1

Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58

Beta Bionics Stockholders Approve Directors and Auditor Ratification

Beta Bionics shareholders elect two directors at annual meeting

Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)

Piper Sandler Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)

Travis Steed Reaffirms Hold on Beta Bionics, Lifts Price Target to $13 on Accelerated Mint Launch but Sees Balanced Risk‑Reward

Beta Bionics Targets 2027 Commercial Launch of Mint Pump

Beta Bionics Inc - Expects Manufacturing Capacity to Meet Demand at Mint Launch

THOMSON REUTERS

Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development

Beta Bionics Is Maintained at Neutral by B of A Securities

Beta Bionics Inc : Bofa Global Research Cuts Price Objective to $11 From $23

THOMSON REUTERS

BofA Adjusts Price Target on Beta Bionics to $11 From $23

MT Newswires Live

Beta Bionics price target lowered to $11 from $23 at BofA

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BBNX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":13.89,"timestamp":1780689600000,"preClose":13.89,"halted":0,"volume":1006979,"hourTrading":{"tag":"盘后","latestPrice":14,"preClose":13.89,"latestTime":"19:01 EDT","volume":1737,"amount":24136.07,"timestamp":1780700509830,"change":0.11,"changeRate":0.007919,"amplitude":0.019438},"delay":0,"changeRate":0,"floatShares":24289699,"shares":44561695,"eps":-1.51137,"marketStatus":"Market Closed","change":0,"latestTime":"06-05 16:00:00 EDT","open":13.78,"high":14.2567,"low":13.71,"amount":14048907.797659999,"amplitude":0.039359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.51137,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":13.89,"preHourTrading":{"tag":"盘前","latestPrice":14.11,"preClose":13.89,"latestTime":"09:12 EDT","volume":217,"amount":3019.809975,"timestamp":1780665147732,"change":0.22,"changeRate":0.015839,"amplitude":0.050396},"postHourTrading":{"tag":"盘后","latestPrice":14,"preClose":13.89,"latestTime":"19:01 EDT","volume":1737,"amount":24136.07,"timestamp":1780700509830,"change":0.11,"changeRate":0.007919,"amplitude":0.019438},"volumeRatio":1.1423349540232202,"impliedVol":0.4625,"impliedVolPercentile":0.078},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":24289699,"roa":"-15.04%","roe":"-22.71%","lyrEps":-1.809999,"volumeRatio":1.1423349540232202,"shares":44561695,"dividePrice":0,"high":14.2567,"amplitude":0.039359,"preClose":13.89,"low":13.71,"week52Low":8.8,"pbRate":"2.28","psRate":"5.61","week52High":32.71,"institutionHeld":0,"latestPrice":13.89,"eps":-1.51137,"divideRate":0,"volume":1006979,"delay":0,"ttmEps":-1.51137,"open":13.78,"prevYearClose":30.47,"prevWeekClose":12.12,"prevMonthClose":12.12,"prevQuarterClose":10.02,"fiveDayClose":12.12,"twentyDayClose":10.5,"sixtyDayClose":10.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"date":"2026-04-21","symbol":"BBNX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2026/03","expectedEps":-0.53,"defaultRemindTime":1776801600000,"name":null,"time":"Post Market","dateTimestamp":1776744000000,"actualEps":null},{"market":"US","date":"2026-02-17","symbol":"BBNX","fiscalQuarterEnding":"2025/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2026-01-08","symbol":"BBNX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1767848400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"BBNX","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2025-07-29","symbol":"BBNX","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753761600000,"reportTimeType":"post","actualEps":-0.39}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.4167,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4167,"analysts":12,"updateTime":1770609600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2026-06-04","current":-9.190337,"percent":0.689349,"low":-18.401318,"twenty":-15.266582,"median":-9.677769,"eighty":-7.842122,"high":-3.90273,"avg":-10.922101,"sd":3.636245,"marketCap":554793102},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293},{"date":"2025-06-13","current":-11.90781,"twenty":-15.527784,"median":-10.843036,"eighty":-8.663027,"marketCap":845013916},{"date":"2025-06-20","current":-10.863051,"twenty":-15.401128,"median":-10.973025,"eighty":-8.671464,"marketCap":770874676},{"date":"2025-06-27","current":-9.158444,"twenty":-15.033515,"median":-10.853044,"eighty":-8.690985,"marketCap":649910652},{"date":"2025-07-03","current":-8.260318,"twenty":-14.588672,"median":-10.413035,"eighty":-8.668829,"marketCap":586176919},{"date":"2025-07-11","current":-8.284756,"twenty":-14.14074,"median":-9.690076,"eighty":-8.535817,"marketCap":587911170},{"date":"2025-07-18","current":-8.043423,"twenty":-13.87507,"median":-9.628891,"eighty":-8.433029,"marketCap":570785439},{"date":"2025-07-25","current":-8.816301,"twenty":-13.38389,"median":-9.506697,"eighty":-8.433029,"marketCap":625631134},{"date":"2025-08-01","current":-10.285126,"twenty":-12.797445,"median":-9.491423,"eighty":-8.48456,"marketCap":729863398},{"date":"2025-08-08","current":-9.243749,"twenty":-12.637058,"median":-9.506697,"eighty":-8.519369,"marketCap":655964186},{"date":"2025-08-15","current":-10.23612,"twenty":-12.367549,"median":-9.430326,"eighty":-8.524348,"marketCap":726385788},{"date":"2025-08-22","current":-10.346383,"twenty":-12.210773,"median":-9.506697,"eighty":-8.53478,"marketCap":734210411},{"date":"2025-08-29","current":-11.461269,"twenty":-12.163662,"median":-9.628891,"eighty":-8.548511,"marketCap":813326038},{"date":"2025-09-05","current":-12.312748,"twenty":-12.179108,"median":-9.681286,"eighty":-8.567484,"marketCap":873749512},{"date":"2025-09-12","current":-15.522638,"twenty":-12.446687,"median":-9.727683,"eighty":-8.641901,"marketCap":1101532967},{"date":"2025-09-19","current":-13.656808,"twenty":-13.735035,"median":-10.052347,"eighty":-8.661432,"marketCap":1001986381},{"date":"2025-09-26","current":-13.111721,"twenty":-13.639034,"median":-10.266749,"eighty":-8.666193,"marketCap":961993866},{"date":"2025-10-03","current":-12.140044,"twenty":-13.564381,"median":-10.319662,"eighty":-8.681485,"marketCap":890702861},{"date":"2025-10-10","current":-13.17097,"twenty":-13.533571,"median":-10.444395,"eighty":-8.70255,"marketCap":966340878},{"date":"2025-10-17","current":-12.222992,"twenty":-13.435219,"median":-10.631231,"eighty":-8.716023,"marketCap":896788678},{"date":"2025-10-24","current":-11.858613,"twenty":-13.293022,"median":-10.863051,"eighty":-8.739096,"marketCap":870054551},{"date":"2025-10-31","current":-15.145803,"twenty":-13.564381,"median":-11.055506,"eighty":-8.749568,"marketCap":1178979618},{"date":"2025-11-07","current":-14.161722,"twenty":-13.91523,"median":-11.228491,"eighty":-8.756685,"marketCap":1102376760},{"date":"2025-11-14","current":-14.840399,"twenty":-14.167423,"median":-11.440151,"eighty":-8.762559,"marketCap":1155206317},{"date":"2025-11-21","current":-16.062017,"twenty":-14.833302,"median":-11.540904,"eighty":-8.774755,"marketCap":1250299520},{"date":"2025-11-28","current":-17.724775,"twenty":-15.145803,"median":-11.576718,"eighty":-8.779642,"marketCap":1379731935},{"date":"2025-12-05","current":-16.966919,"twenty":-15.332439,"median":-11.635852,"eighty":-8.816301,"marketCap":1320738930},{"date":"2025-12-12","current":-16.57668,"twenty":-15.394651,"median":-11.66167,"eighty":-8.816301,"marketCap":1290361934},{"date":"2025-12-19","current":-16.435289,"twenty":-15.547354,"median":-11.719728,"eighty":-8.816301,"marketCap":1279355776},{"date":"2025-12-26","current":-17.583384,"twenty":-15.759893,"median":-11.773049,"eighty":-8.818649,"marketCap":1368725777},{"date":"2026-01-02","current":-17.232734,"twenty":-15.960216,"median":-11.858773,"eighty":-8.819236,"marketCap":1341430506},{"date":"2026-01-09","current":-18.092392,"twenty":-16.141928,"median":-11.883371,"eighty":-8.865131,"marketCap":1408347945},{"date":"2026-01-16","current":-10.061383,"twenty":-16.097911,"median":-11.858773,"eighty":-8.897333,"marketCap":783198185},{"date":"2026-01-23","current":-9.334633,"twenty":-16.07559,"median":-11.773049,"eighty":-8.931179,"marketCap":726626534},{"date":"2026-01-30","current":-8.364691,"twenty":-16.041657,"median":-11.675641,"eighty":-8.819236,"marketCap":651124292},{"date":"2026-02-06","current":-7.488067,"twenty":-15.977182,"median":-11.659491,"eighty":-8.794306,"marketCap":582886114},{"date":"2026-02-13","current":-7.663392,"twenty":-15.919488,"median":-11.620538,"eighty":-8.751152,"marketCap":596533750},{"date":"2026-02-20","current":-8.157068,"twenty":-15.904664,"median":-11.576718,"eighty":-8.716023,"marketCap":597097350},{"date":"2026-02-27","current":-7.894201,"twenty":-15.854571,"median":-11.50475,"eighty":-8.661432,"marketCap":577855540},{"date":"2026-03-06","current":-6.736143,"twenty":-15.718154,"median":-11.419034,"eighty":-8.530548,"marketCap":493085642},{"date":"2026-03-13","current":-6.129829,"twenty":-15.675736,"median":-11.279037,"eighty":-8.463614,"marketCap":448703496},{"date":"2026-03-20","current":-6.548185,"twenty":-15.644631,"median":-11.137987,"eighty":-8.360167,"marketCap":479327176},{"date":"2026-03-27","current":-6.984731,"twenty":-15.542411,"median":-10.896655,"eighty":-8.302628,"marketCap":511282321},{"date":"2026-04-02","current":-6.069198,"twenty":-15.522638,"median":-10.76623,"eighty":-8.280898,"marketCap":444265281},{"date":"2026-04-10","current":-5.838799,"twenty":-15.504261,"median":-10.533127,"eighty":-8.260318,"marketCap":427400065},{"date":"2026-04-17","current":-7.414774,"twenty":-15.438198,"median":-10.441332,"eighty":-8.178055,"marketCap":542761445},{"date":"2026-04-24","current":-7.666283,"twenty":-15.394651,"median":-10.346383,"eighty":-8.156453,"marketCap":509340173},{"date":"2026-05-01","current":-6.841302,"twenty":-15.376414,"median":-10.275938,"eighty":-8.043423,"marketCap":454529289},{"date":"2026-05-08","current":-7.042517,"twenty":-15.372029,"median":-10.061383,"eighty":-7.926138,"marketCap":467897797},{"date":"2026-05-15","current":-6.170586,"twenty":-15.360718,"median":-10.038359,"eighty":-7.859173,"marketCap":409967594},{"date":"2026-05-22","current":-7.116296,"twenty":-15.332439,"median":-9.76729,"eighty":-7.838748,"marketCap":472799583},{"date":"2026-05-29","current":-8.115663,"twenty":-15.317978,"median":-9.690076,"eighty":-7.835348,"marketCap":539196509},{"date":"2026-06-04","current":-8.350413,"twenty":-15.266582,"median":-9.677769,"eighty":-7.842122,"marketCap":554793102}],"updateTime":1780713244078},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2641128205","title":"Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128205","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128205?lang=en_us&edition=fundamental","pubTime":"2026-06-06 06:05","pubTimestamp":1780697144,"startTime":"0","endTime":"0","summary":"Directly held stake fell to 130,612 shares following the transaction.Sale was executed under a Rule 10b5-1 trading plan adopted May 13, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL828LFd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128208","title":"Beta Bionics director Christy Jones sells 2,811 shares worth $39,354","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128208","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128208?lang=en_us&edition=fundamental","pubTime":"2026-06-06 06:05","pubTimestamp":1780697143,"startTime":"0","endTime":"0","summary":"Beta Bionics director Christy Jones sold 2,811 common shares on June 4 at USD 14.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nNDL7SBVNC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beta Bionics director Christy Jones sells 2,811 shares worth $39,354","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640842411","title":"Beta Bionics management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2640842411","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640842411?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:55","pubTimestamp":1780520126,"startTime":"0","endTime":"0","summary":"Meeting to be held on June 9-11 hosted by Piper Sandler.. Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-management-to-meet-with-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640594584","title":"Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard","url":"https://stock-news.laohu8.com/highlight/detail?id=2640594584","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640594584?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:05","pubTimestamp":1780405508,"startTime":"0","endTime":"0","summary":"Beta Bionics launched a public dashboard publishing near real-time real-world performance data for its iLet Bionic Pancreas.The data is available now, ahead of the American Diabetes Association’s 86th Scientific Sessions in June, where it will be referenced.Beta Bionics framed the move as a transparency push designed to help clinicians compare automated insulin delivery options using ongoing outcomes.The dashboard covers all users meeting two pre-set criteria, aiming to reduce selective reporting and support broader evaluation by stakeholders.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL4cdmv8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2095319765.USD","BK4112","LU2210149790.SGD","LU0314104364.USD","BBNX","BK4588","BK4585","SG9999014039.USD","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4082","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BN0W2W23.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640943001","title":"Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2640943001","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640943001?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:00","pubTimestamp":1780405200,"startTime":"0","endTime":"0","summary":"Beta Bionics is setting a new standard in the Automated Insulin Delivery category by making real-world data easy to evaluate and interpret with clearly stated criteria and no exclusions applied, rather than relying on selective populations or optimal performance. The company welcomes others in the industry to publish their real-world data with clear inclusion criteria and no fine print to make it easier for providers and patients to evaluate outcomes with confidence. The dashboard launch comes ahead of the American Diabetes Association’s 86th Scientific Sessions in June, where Beta Bionics will host healthcare providers at its booth and reference the public dashboard in clinical conversations throughout the meeting. About Beta Bionics Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305268/0/en/Beta-Bionics-First-in-Automated-Insulin-Delivery-to-Publish-Near-Real-Time-Real-World-Data-on-a-Public-Website.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638680803","title":"Beta Bionics Is Maintained at Buy by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2638680803","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638680803?lang=en_us&edition=fundamental","pubTime":"2026-05-28 01:42","pubTimestamp":1779903720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2026 13:42 ET (17:42 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638525348","title":"Beta Bionics director Christy Jones disposes of 1,998 common shares worth $19,880.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2638525348","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638525348?lang=en_us&edition=fundamental","pubTime":"2026-05-27 06:01","pubTimestamp":1779832888,"startTime":"0","endTime":"0","summary":"Beta Bionics director Christy Jones sold 1,998 common shares on May 21 at USD 9.95.She also received 16,965 common shares at zero cost on May 21 via a restricted stock unit award.Jones ended the day with 30,211 common shares beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL1BQRnR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638052531","title":"Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2638052531","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638052531?lang=en_us&edition=fundamental","pubTime":"2026-05-27 06:01","pubTimestamp":1779832885,"startTime":"0","endTime":"0","summary":"Beta Bionics director Adam Lezack reported sales of 1,998 common shares at USD 9.95 and USD 11.21 on May 21-22.He also reported acquiring 16,965 common shares at USD 0 on May 21 via a restricted stock unit award.Lezack’s direct holding rose to 27,399 common shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL47MbJr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Beta Bionics director Adam Lezack sells 1,998 common shares for $21,112.58","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637423543","title":"Beta Bionics Stockholders Approve Directors and Auditor Ratification","url":"https://stock-news.laohu8.com/highlight/detail?id=2637423543","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637423543?lang=en_us&edition=fundamental","pubTime":"2026-05-23 05:00","pubTimestamp":1779483658,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) has provided an announcement. On May 21, 2026, Beta Bionics, Inc. held its 2026 Annual Meeting of Stockholders, wher...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-stockholders-approve-directors-and-auditor-ratification?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-stockholders-approve-directors-and-auditor-ratification?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637341702","title":"Beta Bionics shareholders elect two directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2637341702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637341702?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:06","pubTimestamp":1779480396,"startTime":"0","endTime":"0","summary":"Beta Bionics held its annual shareholder meeting on May 21, 2026.Shareholders backed the selection of Sean D. Carney and Christy Jones to serve as Class I directors through the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beta Bionics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL8Py86T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310178","title":"Analysts Offer Insights on Healthcare Companies: Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (BBNX) and Arvinas Holding Company (ARVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310178?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:20","pubTimestamp":1779459618,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Coya Therapeutics, Inc. (COYA), Beta Bionics, Inc. (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-coya-therapeutics-inc-coya-beta-bionics-inc-bbnx-and-arvinas-holding-company-arvn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","XLV","LU0128526141.USD","BK4082","ARVN","BK4139","XBI","HCSG","BBNX","BK4137","BK4588","LABU","BK4581","LU0029874061.USD","COYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637319962","title":"Piper Sandler Sticks to Its Buy Rating for Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637319962","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637319962?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:37","pubTimestamp":1779449869,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-beta-bionics-inc-bbnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-beta-bionics-inc-bbnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637977323","title":"Travis Steed Reaffirms Hold on Beta Bionics, Lifts Price Target to $13 on Accelerated Mint Launch but Sees Balanced Risk‑Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2637977323","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637977323?lang=en_us&edition=fundamental","pubTime":"2026-05-22 17:15","pubTimestamp":1779441319,"startTime":"0","endTime":"0","summary":"Analyst Travis Steed from Bank of America Securities reiterated a Hold rating on Beta Bionics, Inc. and increased the price target to $13.00 from $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/travis-steed-reaffirms-hold-on-beta-bionics-lifts-price-target-to-13-on-accelerated-mint-launch-but-sees-balanced-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/travis-steed-reaffirms-hold-on-beta-bionics-lifts-price-target-to-13-on-accelerated-mint-launch-but-sees-balanced-risk‑reward-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637135357","title":"Beta Bionics Targets 2027 Commercial Launch of Mint Pump","url":"https://stock-news.laohu8.com/highlight/detail?id=2637135357","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637135357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:05","pubTimestamp":1779397507,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. ( ($BBNX) ) has provided an announcement. On May 21, 2026, Beta Bionics announced it plans to fully commercialize Mint, its patc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beta-bionics-targets-2027-commercial-launch-of-mint-pump?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beta-bionics-targets-2027-commercial-launch-of-mint-pump?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637351114","title":"Beta Bionics Inc - Expects Manufacturing Capacity to Meet Demand at Mint Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2637351114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637351114?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393868,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0UB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637148351","title":"Beta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2637148351","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637148351?lang=en_us&edition=fundamental","pubTime":"2026-05-22 04:04","pubTimestamp":1779393840,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May  21, 2026  (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it expects ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299712/0/en/Beta-Bionics-Updates-Commercialization-Timeline-Expectations-for-Mint-its-Patch-Pump-in-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636008208","title":"Beta Bionics Is Maintained at Neutral by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2636008208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636008208?lang=en_us&edition=fundamental","pubTime":"2026-05-19 01:42","pubTimestamp":1779126120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 18, 2026 13:42 ET (17:42 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636073406","title":"Beta Bionics Inc : Bofa Global Research Cuts Price Objective to $11 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2636073406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636073406?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:23","pubTimestamp":1779106984,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nFWN41V10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636907362","title":"BofA Adjusts Price Target on Beta Bionics to $11 From $23","url":"https://stock-news.laohu8.com/highlight/detail?id=2636907362","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636907362?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:10","pubTimestamp":1779106216,"startTime":"0","endTime":"0","summary":"Beta Bionics, Inc. (BBNX) has an average rating of overweight and mean price target of $19.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636078028","title":"Beta Bionics price target lowered to $11 from $23 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2636078028","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636078028?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:00","pubTimestamp":1779105644,"startTime":"0","endTime":"0","summary":"BofA analyst Travis Steed lowered the firm’s price target on Beta Bionics (BBNX) to $11 from $23 and keeps a Neutral rating on the shares. After ha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-11-from-23-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-price-target-lowered-to-11-from-23-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":111,"code":"91000000","status":"200"}]}}